<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01550042</url>
  </required_header>
  <id_info>
    <org_study_id>NL36491.044.11</org_study_id>
    <secondary_id>P11-25</secondary_id>
    <nct_id>NCT01550042</nct_id>
  </id_info>
  <brief_title>Extended Rhythm SCreening for AtRial Fibrillation in Cryptogenic Stroke Patients</brief_title>
  <acronym>SCARF</acronym>
  <official_title>Extended Rhythm SCreening for AtRial Fibrillation in Cryptogenic Stroke Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medisch Spectrum Twente</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medisch Spectrum Twente</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recent studies demonstrated that prolonged rhythm observation increases the detection of
      atrial fibrillation in patients prior diagnosed as cryptogenic stroke. Detection of atrial
      fibrillation in these patients has important therapeutic implications for the anticoagulation
      regimen. However, data on optimal monitoring duration and method of AF detection are limited.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Anticipated">April 2017</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Documented Atrial Fibrillation (AF)</measure>
    <time_frame>One year</time_frame>
    <description>The percentage of patients with documented AF based on implantable cardiac monitor registration during a follow-up period of at least 12 months after an episode of cryptogenic stroke.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to documented AF</measure>
    <time_frame>One year</time_frame>
    <description>Time to documented AF using an Implantable Loop Recorder (ILR) data</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrent stroke</measure>
    <time_frame>One year</time_frame>
    <description>Incidence of recurrent stroke</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">50</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Intensive observation cohort</arm_group_label>
    <description>Patients &gt; 18 years of age diagnosed with a recent episode of cryptogenic stroke with long term rhythm observation using an implantable loop recorder for detecting atrial fibrillation.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted with a ischemic stroke of undetermined etiology
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients &gt; 18 years of age Recent episode (â‰¤60 days) of cryptogenic ischemic stroke

          -  Undetermined etiology with negative evaluation (including cardioembolism work- up)
             according to the criteria for the Trial of Org 10172 in Acute Stroke Treatment (TOAST)

          -  Implantation of an implantable loop recorder within two months after index event

          -  Able of providing informed consent

        Exclusion Criteria:

          -  Pre-existing indication for vitamin K antagonist

          -  Untreated hyperthyroidism

          -  Indication for pacemaker implantation, implantable cardioverter defibrillator (ICD) or
             Cardiac Resynchronisation Therapy (CRT)

          -  Severe co-morbidity not likely to complete follow-up for one year
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marcoen Scholten, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medisch Spectrum Twente</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medisch Spectrum Twente / Thoraxcenter</name>
      <address>
        <city>Enschede</city>
        <state>OV</state>
        <zip>NL7513ER</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <link>
    <url>http://www.mst.nl/thoraxcentre/</url>
    <description>Thoraxcenter</description>
  </link>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 7, 2012</study_first_submitted>
  <study_first_submitted_qc>March 7, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 9, 2012</study_first_posted>
  <last_update_submitted>July 6, 2016</last_update_submitted>
  <last_update_submitted_qc>July 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medisch Spectrum Twente</investigator_affiliation>
    <investigator_full_name>B. Oude Velthuis</investigator_full_name>
    <investigator_title>Research fellow electrophysiology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

